Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes

Behzad Mansoori1, Ali Mohammadi, Solmaz Shirjang

  • 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Insights

MicroRNAs miR-34a and let-7a are downregulated in advanced breast cancer tissues, correlating with altered apoptosis gene expression. These findings suggest their potential as diagnostic and therapeutic markers for late-stage breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a leading cause of cancer mortality in women globally.
  • MicroRNAs (miRNAs) like miR-34a and let-7a are recognized tumor suppressors involved in crucial cellular processes.
  • Dysregulation of miRNAs and apoptosis pathways is implicated in cancer progression.

Purpose of the Study:

  • To investigate the expression levels of miR-34a, let-7a, and key apoptosis-related genes (Bcl-2, Caspase-3, P53) in advanced breast cancer.
  • To explore the correlation between these miRNAs and apoptosis pathway gene expression in tumor tissues.
  • To assess the potential role of miR-34a and let-7a as biomarkers in advanced breast cancer.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) was employed to analyze gene and miRNA expression.
  • Paired normal margin and tumor tissue samples from 45 advanced-stage (3-4) breast cancer patients were analyzed.
  • Statistical analysis was performed to determine correlations between molecular expressions.

Main Results:

  • Expression of miR-34a, let-7a, Caspase-3, and P53 was significantly reduced in tumor tissues compared to normal margin tissues.
  • Expression of the anti-apoptotic gene Bcl-2 was increased in tumor tissues.
  • P53 expression showed a direct or indirect correlation with the expression of miR-34a, let-7a, Bcl-2, and Caspase-3.

Conclusions:

  • Downregulation of miR-34a and let-7a in advanced breast cancer tissues is associated with altered expression of apoptosis-related genes.
  • These miRNAs may function as regulators in advanced breast cancer stages.
  • miR-34a and let-7a hold promise as potential biomarkers for diagnosis, prognostic assessment, and targeted therapy in breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

12.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K